Total Payments
$1,826
2024 Payments
$973.25
Companies
19
Transactions
84
Medicare Patients
265
Medicare Billing
$36,999
Payment Breakdown by Category
Food & Beverage$1,826 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,826 | 84 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $347.42 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $267.86 | 12 | $0 (2024) |
| Amgen Inc. | $180.55 | 18 | $0 (2024) |
| Gilead Sciences, Inc. | $163.94 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $135.10 | 6 | $0 (2024) |
| Lilly USA, LLC | $107.73 | 4 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $78.48 | 4 | $0 (2022) |
| IRONWOOD PHARMACEUTICALS, INC | $71.43 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $64.62 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $57.14 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $973.25 | 51 | Novartis Pharmaceuticals Corporation ($183.84) |
| 2023 | $281.76 | 10 | ABBVIE INC. ($91.44) |
| 2022 | $433.25 | 16 | Gilead Sciences, Inc. ($141.74) |
| 2021 | $137.70 | 7 | AbbVie Inc. ($61.19) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: Inflammation | ||||||
| 10/25/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: HBV | ||||||
| 10/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: Inflammation | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: Inflammation | ||||||
| 09/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.34 | General |
| Category: GI | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: Inflammation | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: Inflammation | ||||||
| 07/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Inflammation | ||||||
| 07/20/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: Inflammation | ||||||
| 07/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 159 | 284 | $62,800 | $22,769 |
| 2022 | 4 | 106 | 171 | $37,595 | $14,230 |
Total Patients
265
Total Services
455
Medicare Billing
$36,999
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 202 | $50,500 | $18,508 | 36.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 18 | 18 | $3,600 | $2,148 | 59.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 22 | 24 | $4,800 | $1,298 | 27.1% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 19 | 19 | $2,850 | $445.74 | 15.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 21 | 21 | $1,050 | $368.76 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 135 | $33,750 | $12,826 | 38.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 14 | 14 | $2,800 | $862.61 | 30.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $495.00 | $309.43 | 62.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 11 | 11 | $550.00 | $231.99 | 42.2% |
About Richard Tan
Richard Tan is a Gerontology healthcare provider based in Alhambra, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2021. The National Provider Identifier (NPI) number assigned to this provider is 1548936602.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Richard Tan has received a total of $1,826 in payments from pharmaceutical and medical device companies, with $973.25 received in 2024. These payments were reported across 84 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,826).
As a Medicare-enrolled provider, Tan has provided services to 265 Medicare beneficiaries, totaling 455 services with total Medicare billing of $36,999. Data is available for 2 years (2022–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Gerontology
- Location Alhambra, CA
- Active Since 08/19/2021
- Last Updated 03/05/2024
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1548936602
Products in Payments
- Otezla (Drug) $180.55
- ENTRESTO (Drug) $177.58
- LINZESS (Drug) $141.46
- AIRSUPRA (Drug) $135.10
- REXULTI (Drug) $102.47
- VIBERZI (Drug) $91.44
- LEQVIO (Drug) $90.28
- MOUNJARO (Drug) $90.05
- Nuedexta (Drug) $78.48
- Linzess (Drug) $71.43
- TRELEGY ELLIPTA (Drug) $64.62
- JARDIANCE (Drug) $57.14
- CORE COGNITIVE EVALUATION (Device) $54.61
- CREON (Drug) $53.33
- AUSTEDO (Drug) $47.41
- ZENPEP (Drug) $42.86
- Dayvigo (Drug) $40.60
- Vemlidy (Drug) $38.94
- VRAYLAR (Drug) $36.37
- UBRELVY (Drug) $24.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.